Literature DB >> 23864055

Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension.

Takuya Kishi1.   

Abstract

Sympathoexcitation has an important role in the pathogenesis of hypertension. Previous studies have demonstrated that nitric oxide (NO) and/or oxidative stress in the brain are important for the regulation of the sympathetic nervous system. We have investigated the role of NO derived from an overexpression of endothelial NO synthase (eNOS) or oxidative stress in the rostral ventrolateral medulla (RVLM), which is known as a vasomotor center in the brainstem, on the regulation of the sympathetic nervous system. Our results indicated that NO derived from an overexpression of eNOS in the RVLM caused sympathoinhibition via an increase in γ-amino butyric acid and that angiotensin II type 1 receptor (AT1R)-induced oxidative stress in the RVLM caused sympathoexcitation. We also demonstrated that oxidative stress in the RVLM caused sympathoexcitation via interactions with NO, effects on the signal transduction or apoptosis of the astrocytes. Furthermore, several orally administered AT1R blockers have been found to cause sympathoinhibition via a reduction in oxidative stress through the blockade of AT1R in the RVLM of hypertensive rats. In conclusion, our studies suggest that the increase in AT1R-induced oxidative stress and/or the decrease in NO in the RVLM mainly cause sympathoexcitation in hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23864055     DOI: 10.1038/hr.2013.73

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  20 in total

1.  Hypertension at high altitude: the interplay between genetic and biochemical factors in the setting of oxidative stress.

Authors:  Mohammad Z Ashraf
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

Review 2.  The Orexin System and Hypertension.

Authors:  Michael J Huber; Qing-Hui Chen; Zhiying Shan
Journal:  Cell Mol Neurobiol       Date:  2017-03-27       Impact factor: 5.046

3.  TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase.

Authors:  Tadaaki Nakashima; Seiji Umemoto; Koichi Yoshimura; Susumu Matsuda; Shinichi Itoh; Tomoaki Murata; Tohru Fukai; Masunori Matsuzaki
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

4.  Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.

Authors:  Renata V Tiradentes; Cintia H Santuzzi; Erick Rg Claudio; Vinicius Mengal; Nyam F Silva; Henrique A F Neto; Nazaré S Bissoli; Glaucia R Abreu; Sonia A Gouvea
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

Review 5.  The crosstalk between autonomic nervous system and blood vessels.

Authors:  Yulan Sheng; Li Zhu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

Review 6.  Innate and Innate-Like Immune System in Hypertension and Vascular Injury.

Authors:  Akinori Higaki; Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

7.  Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats.

Authors:  Tomoko Yoshikawa; Takuya Kishi; Keisuke Shinohara; Ko Takesue; Risa Shibata; Noriyuki Sonoda; Toyoshi Inoguchi; Kenji Sunagawa; Hiroyuki Tsutsui; Yoshitaka Hirooka
Journal:  Hypertens Res       Date:  2017-02-16       Impact factor: 3.872

Review 8.  The organ-specific nitric oxide synthase activity in the interaction with sympathetic nerve activity: a hypothesis.

Authors:  S Liskova
Journal:  Physiol Res       Date:  2021-04-30       Impact factor: 1.881

9.  Effect of iron oxide nanoparticles on vascular function and nitric oxide production in acute stress-exposed rats.

Authors:  S Líšková; P Bališ; A Mičurová; M Kluknavský; M Okuliarová; A Puzserová; M Škrátek; I Sekaj; J Maňka; P Valovič; I Bernátová
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

10.  Blood pressure-lowering effect of repeated Waon therapy in non-smokers with hypertension.

Authors:  Kazuyuki Kominami; Etsuko Takahiza; Mineko Tabuchi; Masatoshi Akino
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.